Editorial
Published on 28 Jul 2025
Editorial: Safety of corticosteroids in respiratory medicine
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1656299
- 1,374 views
Type at least 3 characters
13 articles
Review
Published on 24 Apr 2025
Corticosteroids in lung cancer
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
- 3,686 views
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 1,715 views
Original Research
Published on 13 May 2024
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1334468
- 2,121 views
- 1 citation
Editorial
Published on 05 Feb 2024
Editorial: Treatment of comorbidities of asthma and its safety
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1366847
- 1,286 views
Review
Published on 14 Dec 2023
Safety of corticosteroid therapy in sarcoidosis treatment
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1319931
- 2,833 views
Review
Published on 07 Nov 2023
Promising treatment biomarkers in asthma
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1291471
- 2,951 views
- 5 citations
Mini Review
Published on 16 Feb 2023
Balancing the evidence: An update on analgesic use in rheumatic and musculoskeletal diseases
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1117674
- 3,204 views
- 4 citations
Original Research
Published on 09 Jan 2023
Adverse events in rheumatoid arthritis patients under antimalarial treatment—Is there cardiovascular compromise?
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.1044696
- 2,246 views
Review
Published on 23 Dec 2022
Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.1011701
- 7,600 views
- 14 citations
Original Research
Published on 19 Oct 2022
Putting external validation performance of major bleeding risk models into context
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.1034677
- 1,164 views
Specialty Grand Challenge
Published on 05 Apr 2022
Current Status and Future Challenges in the Treatment of Rheumatic Diseases
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.881556
- 4,558 views
- 6 citations
Specialty Grand Challenge
Published on 29 Oct 2021
Moving to a Personalized Approach in Respiratory Medicine. From Academic Research to Regulatory Intervention
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2021.752581
- 2,423 views
- 4 citations